Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pleural Mesothelioma Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05910112
What this trial is testing

Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention

Who this might be right for
Pleural DiseasesPleural MesotheliomaPneumothorax+7 more
University of Oxford 2,000
Early research (Phase 1)UnknownNCT00006216
What this trial is testing

Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma

Who this might be right for
Malignant Mesothelioma
Louisiana State University Health Sciences Center in New Orleans
Not applicableLooking for participantsNCT06886672
What this trial is testing

Genetic Susceptibility in MAlignant Pleural Mesothelioma: Clinical Implication of GermliNE variaTionS

Who this might be right for
Mesothelioma, Malignant Pleural
Fondazione IRCCS Policlinico San Matteo di Pavia 60
Not applicableStudy completedNCT05308966
What this trial is testing

Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)

Who this might be right for
Malignant Pleural MesotheliomaUnresectable Malignant Neoplasm
Groupe Francais De Pneumo-Cancerologie 204
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07131345
What this trial is testing

Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma

Who this might be right for
Malignant MesotheliomaMesothelioma
National Cancer Center, China 55
Large-scale testing (Phase 3)UnknownNCT00003034
What this trial is testing

ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen

Who this might be right for
Malignant Mesothelioma
Alfacell 300
Testing effectiveness (Phase 2)Study completedNCT00004254
What this trial is testing

Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed

Who this might be right for
Malignant Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC 25
Early research (Phase 1)Study completedNCT00055705
What this trial is testing

PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00509041
What this trial is testing

Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Alliance for Clinical Trials in Oncology 46
Testing effectiveness (Phase 2)Study completedNCT00006014
What this trial is testing

SU5416 in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
National Cancer Institute (NCI) 45
Early research (Phase 1)Looking for participantsNCT07532902
What this trial is testing

BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer

Who this might be right for
Diffuse Pleural MesotheliomaGastroesophageal CarcinomaUrothelial Carcinoma
Memorial Sloan Kettering Cancer Center 60
Early research (Phase 1)WithdrawnNCT02661659
What this trial is testing

A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy

Who this might be right for
Malignant Pleural Mesothelioma (MPM)
University of Chicago
Testing effectiveness (Phase 2)Ended earlyNCT03175172
What this trial is testing

Evaluation of CRS-207 With Pembrolizumab in Previously Treated Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Malignant Pleural Mesothelioma
Aduro Biotech, Inc. 10
Testing effectiveness (Phase 2)UnknownNCT01649024
What this trial is testing

A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Azienda Ospedaliera Universitaria Senese 29
Testing effectiveness (Phase 2)Study completedNCT00859469
What this trial is testing

Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma

Who this might be right for
Mesothelioma
Columbia University 29
Early research (Phase 1)Study completedNCT00402766
What this trial is testing

Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma

Who this might be right for
Mesothelioma
M.D. Anderson Cancer Center 19
Testing effectiveness (Phase 2)Study completedNCT05795595
What this trial is testing

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaCervical CarcinomaEsophageal Carcinoma+2 more
CRISPR Therapeutics AG 19
Testing effectiveness (Phase 2)Study completedNCT00365053
What this trial is testing

PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more
National Cancer Institute (NCI) 13
Not applicableStudy completedNCT02214134
What this trial is testing

SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access

Who this might be right for
Any Stage of Lung Cancer (Any Histotype)Any Stage of Malignant Pleural MesotheliomaAny Stage of Any Thymic Malignancy
European Organisation for Research and Treatment of Cancer - EORTC 539
Not applicableEnded earlyNCT02613312
What this trial is testing

Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma

Who this might be right for
MesotheliomaSolitary Fibrous Tumor of the Pleura
Mayo Clinic 8
Next Page